Approved second supplement to the prospectus of the public

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
32
Approved second supplement to the prospectus of the public offering of INVL Baltic Real Estate

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE STOCK EXCHANGE RELEASE.

On 27 August 2018 Director of the Supervision Service of the Bank of Lithuania by the decision No. 241-196 approved the second supplement to the prospectus of the public offering (hereinafter, the “Second Supplement to the Prospectus”, please see the attached documents) of INVL Baltic Real Estate  (hereinafter, the “Company”). The Prospectus of INVL Baltic Real Estate  was approved by the Bank of Lithuania and  published by the Company on 23 April 2018  (decision regarding approval of the Prospectus No. 241-70, the “Prospectus”), later replaced with the first supplement to the prospectus, approved by the Director of the Supervision Service of the Bank of Lithuania and published by the Company on 21 May 2018 (decision regarding approval of the supplement to the prospectus No. 241-128).

This Second Supplement has been approved and announced taking into consideration that (i) on 17 August 2018 the Company has announced the Group’s consolidated interim condensed not-audited financial statements for the six months ended 30 June 2018, (ii) the new valuation reports of real estate property of the Group were issued, (iii) the Company announced the forecast of the Company for the year ended 2018 as invalid on 17th August 2018, this forecast was included in the Prospectus as well as that (iv) amendments to certain tax laws of the Republic of Lithuania were passed on 28th June 2018, which may be relevant for certain investors of the Company.

All other conditions remain unchanged and are the same as stated in the material event of the approval of the Prospectus published by the Company on 23 April 2018, i.e. the Public offering  is executed by Invalda INVL AB (hereinafter referred, the „Selling Shareholder“), which on the day of the Prospectus and on this announcement day is the largest shareholder of the Company. During the Public Offering, the Selling Shareholder sells up to 2,893,000 units of existing ordinary registered shares of the Company, which represent up to 22% of the Company's share capital. INVL Finasta UAB FMĮ was appointed as the offering broker, executing the offering under the Prospectus, according to the first supplement to the Prospectus on 21 May 2018.

According to the Prospectus (also taking into account the Supplements to the Prospectus), the Offering consists of Public Offering in the Republic of Lithuania; and a private placement to Institutional Investors outside of the United States of America (excluding Lithuania) in reliance on Regulation S under the U.S. Securities Act of 1933. The Offering also covers private offering of Offer Shares to individually identified non-institutional and non-qualified investors.

The Public Offering price:

The Public Offering shares are being offered at the Public Offering Price (hereinafter, the “Offer Price”), which is established based on this formula:

OP = NAV/Shares, where

OP – Offer Price applicable to the particular Offering Period;

NAV – the latest Net Asset Value (the difference between the value of assets owned by the Company and long-term and current liabilities of the Company), which was announced prior to commencement of the particular Offering Period;

Shares – number of outstanding Shares of the Company (13,150,000).

The Offer Price is the same for all the Investors. However, taking into consideration that following the requirements of the applicable legal acts and the Articles of Association, the calculations of the Net Asset Value is performed and announced at least once per three months, the Offer Price during the different Offering Periods may be different (depending on the announced NAV). In any case it will be ensured, that during the same Offering Period the Offer Price calculated based on the above formula shall be the same.

Expected Public Offering Periods  (Acceptance of the Purchase Orders from the Investors):

- from 2 May 2018 till 4 July 2018 (from 9 a.m. until 5 p.m. Vilnius time) - period is completed on this announcement day ; - from 18 August 2018 till 18 September 2018 (from 9 a.m. until 5 p.m. Vilnius time); - from 2 November 2018 till 13 December 2018 (from 9 a.m. until 5 p.m. Vilnius time).

The Selling Shareholder reserves the right to change the timetable of the Periods of the Public Offering. Should the Selling Shareholder decide to materially adjust the dates set out in the timetable, the relevant supplement to the Prospectus will be provided to the Bank of Lithuania for the approval and published (upon the approval) in compliance with applicable regulations, as well as market practices in Lithuania.

Details of the submission and payment of the purchase orders, as well as other Public Offering Conditions, are indicated in the Prospectus (also taking into account the Supplements to the Prospectus).

IMPORTANT NOTICE:

This notification is not for distribution to United States newswire services or for dissemination in the United States, Canada, Japan or Australia or elsewhere where such dissemination is not appropriate.

Distribution of this announcement and other information in connection with the Company may be restricted by law in certain jurisdictions. Persons into whose possession this announcement or such other information should come are required to inform themselves about and to observe any such restrictions.

No offer or invitation to acquire securities of the Company is being made by or in connection with this notification. Any such offer is made solely by means of the Prospectus (also taking into account the Supplements to the Prospectus) and the Prospectus (also taking into account the Supplements to the Prospectus) is the only legally binding document containing information on the Company and on the Company’s shares. The Prospectus (also taking into account the Supplements to the Prospectus) is published through GlobeNewswire, the on-line information system of AB Nasdaq Vilnius, and on the Company’s website  www.invlbalticrealestate.lt  and (for information purposes only) on the management company's website at  www.invl.com .

In addition, the Prospectus (also taking into account the Supplements to the Prospectus) has been prepared on the grounds that there will be no public offering of the shares of the Company, except for a public offering in the Republic of Lithuania in accordance with the 2003 Act. November 4 Directive 2003/71 / EC of the European Parliament and the Council on the Prospectus to be published when shares are offered to the public or admitted to trading and amending Directive 2001/34 / EC as implemented by Lithuania.

The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States or to US persons unless the securities are registered under the Securities Act, or an exemption from the registration requirements of the Securities Act is available. No public offering of the securities will be made in the United States.

The person authorized to provide additional information:          Real Estate Fund Manager of Management Company          Vytautas Bakšinskas          E-mail vytautas.baksinskas@invl.com

Attachments

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

TRIMEDX Earns Spot in 2024 Inspiring Workplaces Rankings

Updated Category News Views 62

TRIMEDX Recognized as One of the Top Inspiring Workplaces TRIMEDX, a leading name in clinical asset management, has proudly claimed the 30th spot on the 2024 Global Top 100 Inspiring Workplaces list. This esteemed recognition highlights organizations that prioritize people-first practices and create outstanding workplace environments. A Global Overview The Inspiring...

Continue Reading
Triumvirate Environmental Secures Major Investment Boost

Updated Category News Views 326

Triumvirate Environmental Announces $1.8 Billion Valuation Triumvirate Environmental, a prominent name in environmental services, has recently received a significant growth investment from Berkshire Partners, a well-respected private equity firm. This monumental partnership has led to Triumvirate being valued at $1.8 billion, a testament to its strong market position and...

Continue Reading
Investing in MSCI: A Journey Over 15 Years Explained

Updated Category News Views 198

The Growth of MSCI Over 15 Years MSCI (NYSE: MSCI) has demonstrated impressive performance over the past decade and a half, significantly outperforming the market. With an annualized return of 20.17%, MSCI has amassed a market capitalization of $43.82 billion. This remarkable performance speaks volumes about the company’s solid market positioning and timely strategic...

Continue Reading
Deckers Outdoor Surges in Premarket Trading After Strong Earnings Report

Updated Category News Views 243

Deckers Outdoor Impresses with Strong Financial Results Shares of Deckers Outdoor Corporation (NYSE: DECK) have recently experienced a notable increase in value. This uplift can be attributed to the company's impressive second-quarter earnings, which surpassed analysts' expectations. The casual footwear and apparel retailer reported revenue of $1.31 billion, significantly...

Continue Reading
Vitrolife Group Secures Major Financing Through Nordic Banks

Updated Category News Views 190

Vitrolife AB Strengthens Financial Backbone Vitrolife AB (publ) has taken a significant step towards enhancing its financial foundation by renewing and signing a loan agreement worth EUR 300 million. This strategic financial maneuver includes both a term loan and a revolving credit facility, aimed at refinancing existing debt while also providing resources for general...

Continue Reading